sapropterin dihydrochloride
NDC 31722-045, sapropterin dihydrochloride, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-045
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215534
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SAPROPTERIN DIHYDROCHLORIDE100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Phenylalanine Hydroxylase Activator [EPC]; Phenylalanine Hydroxylase Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-045-12 | 31722004512 | 120 TABLET in 1 BOTTLE (31722-045-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ec8ea96c-8ec1-4301-a85d-d59562e548ca
Use it
Look up 31722-045 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.